Your browser doesn't support javascript.
loading
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
Yagi, Yu; Kanemasa, Yusuke; Sasaki, Yuki; Hayashi, Yudai; Mino, Mano; Kato, Chika; Sakai, Satoshi; Ohigashi, An; Kanbara, Yasuhiro; Morita, Yuka; Tamura, Taichi; Atsuta, Yuya; Konuma, Ryosuke; Nakamura, Shohei; Wada, Atsushi; Okuya, Toshihiro; Kageyama, Akihiko; Murakami, Daisuke; Nakashima, Shiori; Uchibori, Yusuke; Onai, Daishi; Hamamura, Atsushi; Nishijima, Akihiko; Omuro, Yasushi; Shingai, Naoki; Shimizuguchi, Takuya; Toya, Takashi; Shimizu, Hiroaki; Najima, Yuho; Kobayashi, Takeshi; Haraguchi, Kyoko; Ohashi, Kazuteru; Doki, Noriko; Okuyama, Yoshiki; Shimoyama, Tatsu.
Afiliação
  • Yagi Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kanemasa Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Sasaki Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Hayashi Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Mino M; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kato C; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Sakai S; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Ohigashi A; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kanbara Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Morita Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Tamura T; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Atsuta Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Konuma R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Nakamura S; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Wada A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Okuya T; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kageyama A; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Murakami D; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Nakashima S; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Uchibori Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Onai D; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Hamamura A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Nishijima A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Omuro Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Shingai N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Shimizuguchi T; Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Shimizu H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Haraguchi K; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Okuyama Y; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
  • Shimoyama T; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
Rinsho Ketsueki ; 63(10): 1363-1372, 2022.
Article em Ja | MEDLINE | ID: mdl-36351641
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies Limite: Humans Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies Limite: Humans Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2022 Tipo de documento: Article